PIPA551917

XKR3 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA551917-Each-of-1 In Stock ₹ 48,905.50

PIPA551917 - Each of 1

₹ 48,905.50

In Stock

Quantity

1

Base Price: ₹ 48,905.50

GST (18%): ₹ 8,802.99

Total Price: ₹ 57,708.49

Antigen

XKR3

Classification

Polyclonal

Conjugate

Unconjugated

Gene

XKR3

Gene Alias

expressed in testis; X Kell blood group precursor-related family, member 3; x Kell blood group-related 3; XK related 3; XK, Kell blood group complex subunit-related family, member 3; XKR3; XK-related protein 3; X-linked Kx blood group related 3; XRG3; XTES

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

150165

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Immunohistochemistry

Concentration

0.05 mg/mL

Formulation

PBS with 40% glycerol and 0.02% sodium azide; pH 7.2

Gene Accession No.

Q5GH77

Gene Symbols

XKR3

Immunogen

Recombinant protein corresponding to Human XKR3

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA551858

--

Img

Thermo Scientific

PIPA554854

--

Img

Thermo Scientific

PIPA551733

--

Img

Thermo Scientific

PIPA556651

--

Img

Thermo Scientific

PIPA551846

--

Img

Thermo Scientific

PIPA554803

--

Img

Thermo Scientific

PIPA536613

--

Img

Thermo Scientific

PIPA5111033

--

Description

  • Immunogen sequence: TIRNYHKWLK NLKQEKEETQ VSITKRNTML EREIAFSIRD NFMQQKAFK Highest antigen sequence identity to the following orthologs: Mouse - 29%, Rat - 31%
  • XKRX (MIM 300684) and XKR3 are homologs of the Kell blood group precursor XK (MIM 314850), which is a putative membrane transporter and a component of the XK/Kell complex of the Kell blood group system (Calenda et al., 2006 [PubMed 16431037]).[supplied by OMIM, Mar 2008].